|
|
Volumn 39, Issue 1, 2000, Pages 2-5
|
|
Resistant rheumatoid arthritis clinics - A necessary development?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
CELECOXIB;
CYCLOSPORIN A;
ETANERCEPT;
HYDROXYCHLOROQUINE;
INFLIXIMAB;
LEFLUNOMIDE;
METHOTREXATE;
ROFECOXIB;
SALAZOSULFAPYRIDINE;
COMBINATION CHEMOTHERAPY;
DISEASE ACTIVITY;
DISEASE COURSE;
DRUG EFFICACY;
EDITORIAL;
HEALTH CARE COST;
HUMAN;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
SIDE EFFECT;
TREATMENT OUTCOME;
|
|
EID: 0033962659
PISSN: 14620324
EISSN: None
Source Type: Journal
DOI: 10.1093/rheumatology/39.1.2 Document Type: Editorial |
|
Times cited : (15)
|
|
References (14)
|
